[Characteristics of Metrazol and Megimide for activation of seizure discharge--experimental study and their clinical uses].
D000293:Adolescent; D000328:Adult; D000818:Animals; D001534:Bemegride / Q000494:pharmacology*; D001835:Body Weight; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects; D002648:Child; D004569:Electroencephalography; D004827:Epilepsy; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010433:Pentylenetetrazole / Q000494:pharmacology*
D001534:Bemegride; D010433:Pentylenetetrazole